Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort studyArticle Published on 2022-09-222022-11-16 Journal: Nephrology, dialysis, transplantation : official p [Category] SARS, 변종, [키워드] adjusted Admissions age analyzed clinical epidemiology cohort study Comorbidity Course COVID-19 Cox proportional hazard dialysis died disease severity dissemination dominant dose doses driven by Efficacy first dose Hemodialysis high risk Hospitalized incidence Infection information less majority Mild observation period omicron Patient positive predictor variable provided reducing reduction in Regression model risk SARS-CoV-2 SARS-COV-2 infection second dose Severity of infection the epidemic vaccination Vaccine vaccine doses variant [DOI] 10.1093/ndt/gfac209 PMC 바로가기
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upArticle Published on 2022-09-192022-11-15 Journal: BMJ Open [Category] SARS, 변종, 진단, [키워드] 95% CI age antibody asked Belgium booster vaccination Care circulation cohort study Complete COVID-19 COVID-19 infection dominant eight eligible Epidemiology Follow-up general medicine (see internal medicine) Health Healthcare provider IgM and IgG incidence internal Longevity measure natural infection participant Participants participated Patient patients physically Prevalence primary care Prospective prospective cohort study provided questionnaire reached Receptor binding domain Registered SARS-CoV-2 SARS-CoV-2 antibody secondary outcome serological test supported vaccination variant virus women [DOI] 10.1136/bmjopen-2022-065897 PMC 바로가기
COVID-19 in New South Wales children during 2021: severity and clinical spectrumArticle Published on 2022-09-192022-11-16 Journal: The Medical journal of Australia [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI acute respiratory syndrome adjusted odds ratio Admission Admissions age analyses Analysis Asymptomatic Care Childhood diseases children chronic respiratory disease clinical factor cohort study coronavirus coronavirus disease COVID-19 declined delta variant Epidemics Frequency greater Health home care Home care services, hospital-based hospital Hospital admission hospitalised infancy Infants infections Inflammatory intensive care likelihood Local Medical conditions morbidity MOST network New outbreak outcome positive Prospective random SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid severity South syndrome Virtual care were recorded wheeze with mild disease [DOI] 10.5694/mja2.51661 PMC 바로가기
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in CataloniaArticle Published on 2022-09-162022-11-15 Journal: BMC Medicine [Category] SARS, 진단, [키워드] Adults age Analysis antibody Antibody Response asymptomatic infection benefit booster dose Breakthrough infection cardiovascular diseases Characteristics cohort study Comorbidities COVID-19 COVID-19 testing COVID-19 vaccination COVID-19 vaccines determinants disease dose Electronic health record Host IgA IgG IgG level IgG RBD IgM IgM response immune response Immunity increase in infected individuals Infection janssen Kinetics less Mental mRNA vaccine multivariable nucleocapsid antigen occurred participant predicted prevalent RBD reflected Regression analyses response responses Result SARS-CoV-2 SARS-CoV-2 antibody responses SARS-COV-2 infection SARS-CoV-2 spike Sex smoking Sociodemographic characteristics statistically significant Support trajectory vaccination Vaccine was related [DOI] 10.1186/s12916-022-02547-2 PMC 바로가기
Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch childrenArticle Published on 2022-09-092022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] 95% CI affected antibodies antibody antibody assay Antibody assays Antibody prevalence association children clinical variables cohort study Concordance cross-sectional Demographic variables difference evaluate healthy children Humoral immunity IgA IgG IgG positivity Immunity Immunocompromised infected children Infection investigated medical service MONITOR mucosal mucosal antibody response mucosal IgG Netherland Non-invasive performed positive Prevalence prospective cohort RBD RBD-specific IgG Receptor binding domain reduced Saliva saliva antibodies. SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 spike serum Sex Symptom vaccination [DOI] 10.3389/fimmu.2022.976382 PMC 바로가기
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego CountyArticle Published on 2022-09-052022-10-05 Journal: Addiction Science & Clinical Practice [Category] SARS, 임상, [키워드] analyses Antigen board cohort study Community condition COVID-19 COVID-19 testing COVID-19 vaccination develop Diego drug effect size Efficacy estimate event facilitate finding Follow-up harm reduction health authorities Health status impacted include information intake Intervention intravenous lesson Local Motivational interviewing offer organization outcomes participant pilot study Population populations Precision protocol Randomized Randomized controlled trial RCT recruit reduction Registered SARS-CoV-2 severe disease state health department Study design substance Substance use Support Trial vaccination Vulnerable populations [DOI] 10.1186/s13722-022-00328-z PMC 바로가기 [Article Type] Article
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021Article Published on 2022-09-022022-11-16 Journal: BMC Medicine [Category] SARS, 변종, [키워드] adjusted Admissions age AZD1222 BNT162b2 booster Care change changes in Cohort studies cohort study Combination Comorbidities conditions confidence interval country covariate COVID-19 COVID-19 vaccine COVID-19 vaccines death delta variant dominant dose effective Effectiveness facilitated groups hazard heterologous schedules highest hospitalisation hospitalisations Hospitalization Infection intensive care intensive care units knowledge Mortality mRNA mRNA-1273 National Norway pandemic population-based cohort proportional hazards models provided receiving regimen regimens registries remained SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections second dose Sex Support the vaccine vaccination Vaccine vaccine dose vaccine effectiveness waned [DOI] 10.1186/s12916-022-02480-4 PMC 바로가기
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort studyMulticenter Study Published on 2022-09-012022-10-05 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 바이오마커, 진단, [키워드] 1:1 95% CI benefit cohort study Complication Confirmed COVID-19 infection COVID-19 criteria Critically ill Critically ill patient Effectiveness elderly evaluate ICU ICUs in-hospital mortality intensive care unit mechanical ventilation Mortality multicenter objective Older older adult P-value Patient patients with COVID-19 Primary outcome Propensity score Respiratory failure Result Retrospective study safety profile SARS-CoV-2 selected severe COVID-19 statistically significant difference Support TCZ Tocilizumab two group Ventilator-free days was used with COVID-19 [DOI] 10.1016/j.ijid.2022.05.038 [Article Type] Multicenter Study
Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort StudyArticle Published on 2022-09-012022-11-15 Journal: Infection Control and Hospital Epidemiology [Category] SARS, 진단, [키워드] 95% confidence interval Abbott adjusted analyzed anti-Nucleocapsid IgG antibody status baseline Baseline serology baseline serostatus changes in checked Chicago cohort study coronavirus disease COVID-19 criteria demographics determine Follow-up HCW HCWs healthcare worker identify Infection median moderate Month participant PCR PCR positive polymerase chain positive positive PCR Prospective recruited Reinfection Respiratory Coronavirus risk SARS-CoV-2 SARS-COV-2 infection seroconverted serologic serology serology testing seronegative seronegative participant seropositive Seropositivity setting status virus was used were assessed worker [DOI] 10.1017/ice.2021.367 PMC 바로가기
Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort studyArticle Published on 2022-09-012022-11-16 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), SARS, 치료기술, [키워드] anticancer AP-HP Cancer patients Care categories clinical presentation cohort study collected COVID-19 Deleterious delivery delivery of health care diagnose diagnosed Early Cancer Early cancer detection Electronic health record Health hospitals impacted influence initial lockdown lung cancer lung cancer patient lung neoplasms management multicentre outbreak outcome pandemic Paris Patient Prognosis Quality Quality of Health Care receive recorded remained retrieved retrospective Routinely collected health data. SARS-CoV-2 pandemic supportive care survival the SARS-CoV-2 therapy Treatment treatment initiation university [DOI] 10.1016/j.ejca.2022.06.018 PMC 바로가기